Target
Mu-type opioid receptor
Ligand
BDBM239907
Substrate
n/a
Meas. Tech.
Binding Assay
Temperature
298.15±n/a K
Ki
27±n/a nM
Comments
extracted
Citation
 Nolte, BSchröder, WLinz, KEnglberger, WSchick, HGraubaum, HBraun, BOzegowski, SBálint, JSonnenschein, H Substituted 4-aminocyclohexane derivatives US Patent  US9403767 Publication Date 8/2/2016 
Target
Name:
Mu-type opioid receptor
Synonyms:
M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
44789.51
Organism:
Homo sapiens (Human)
Description:
P35372
Residue:
400
Sequence:
MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
  
Inhibitor
Name:
BDBM239907
Synonyms:
US9403767, 72 | US9403767, 73
Type:
Small organic molecule
Emp. Form.:
C23H29F3N2
Mol. Mass.:
390.485
SMILES:
CN(C)C1(CCC(CC1)(N(C)C)c1ccc(cc1)C(F)(F)F)c1ccccc1 |(-1.65,-6.62,;-.11,-6.57,;-.22,-8.11,;.61,-5.21,;1.94,-4.44,;1.94,-2.9,;.61,-2.13,;-.72,-2.9,;-.72,-4.44,;1.33,-.77,;1.44,.77,;2.87,-.72,;-.11,-.77,;-1.65,-.72,;-2.37,.64,;-1.56,1.95,;-.02,1.9,;.7,.54,;-2.28,3.31,;-3,4.67,;-3.64,2.59,;-.92,4.03,;1.33,-6.57,;2.87,-6.62,;3.6,-7.98,;2.78,-9.29,;1.24,-9.24,;.52,-7.88,)|
Structure:
Search PDB for entries with ligand similarity: